Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3419)
All Articles published online
|
Nov 14, 2005 (publication date) through Dec 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zekri ARN, Ashour MSED, Hassan A, El-Din HMA, El-Shehaby AM, Abu-Shady MA. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression. World J Gastroenterol 2005; 11(42): 6624-6630 [PMID: 16425355 DOI: 10.3748/wjg.v11.i42.6624] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i42/6624.htm |
| Number | Citing Articles |
| 1 |
Noha G. Bader El Din, Sally Farouk, Reem El-Shenawy, Mostafa M. Elhady, Marwa K. Ibrahim, Reham M. Dawood, Ahmed M. Salem, Mostafa K. El Awady. The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 Patients. Viral Immunology 2017; 30(2): 127 doi: 10.1089/vim.2016.0083
|
| 2 |
Antonino Tuttolomondo, Domenico Di Raimondo, Chiara Bellia, Giuseppe Clemente, Rosaria Pecoraro, Carlo Maida, Irene Simonetta, Valerio Vassallo, Danilo Di Bona, Eliana Gulotta, Marcello Ciaccio, Antonio Pinto, Jose Ignacio Herrero. Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites. PLOS ONE 2016; 11(12): e0165443 doi: 10.1371/journal.pone.0165443
|
| 3 |
Abdel-Rahman N Zekri, Hanaa M Alam El-Din, Abeer A Bahnassy, Naglaa A Zayed, Waleed S Mohamed, Suzan H El-Masry, Sayed K Gouda, Gamal Esmat. Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4. Comparative Hepatology 2010; 9(1) doi: 10.1186/1476-5926-9-1
|
| 4 |
Cosimo Marcello Bruno, Maria Valenti, Gaetano Bertino, Annalisa Ardiri, Alfredo Amoroso, Maria Consolo, Clorinda Maria Mazzarino, Sergio Neri. Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitis. Annals of Saudi Medicine 2011; 31(4): 360 doi: 10.4103/0256-4947.83215
|
| 5 |
Mohamed I. Radwan, Heba F. Pasha, Rasha H. Mohamed, Hala I.M. Hussien, Mohamed N. El-Khshab. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients. Cytokine 2012; 60(1): 271 doi: 10.1016/j.cyto.2012.05.010
|
| 6 |
Ahmed Babiker, Mohamed Hassan, Safwan Muhammed, Gregory Taylor, Bhawna Poonia, Anoop Shah, Shashwatee Bagchi. Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review. Clinical Cardiology 2020; 43(3): 222 doi: 10.1002/clc.23299
|
| 7 |
Manuela G. Neuman, Kevin Sha, Rustan Esguerra, Sam Zakhari, Robert E. Winkler, Nir Hilzenrat, Jonathan Wyse, Curtis L. Cooper, Devanshi Seth, Mark D. Gorrell, Paul S. Haber, Geoffrey W. McCaughan, Maria A. Leo, Charles S. Lieber, Mihai Voiculescu, Eugenia Buzatu, Camelia Ionescu, Jozsef Dudas, Bernhard Saile, Giuliano Ramadori. Inflammation and Repair in Viral Hepatitis C. Digestive Diseases and Sciences 2008; 53(6) doi: 10.1007/s10620-007-0047-3
|
| 8 |
Mohamed El-Shahat Ebeid, Kadry Abdel-Kader El-Bakry. Cellular immune response to infection by different genotypes of hepatitis C virus. Indian Journal of Clinical Biochemistry 2009; 24(3): 234 doi: 10.1007/s12291-009-0044-8
|
| 9 |
Manuela G. Neuman, Hemda Schmilovitz-Weiss, Nir Hilzenrat, Marc Bourliere, Patrick Marcellin, Cristhian Trepo, Tony Mazulli, George Moussa, Ankit Patel, Asad A. Baig, Lawrence Cohen. Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/231210
|
| 10 |
T Motawi, OG Shaker, RM Hussein, M Houssen. Polymorphisms of α1-antitrypsin and Interleukin-6 genes and the progression of hepatic cirrhosis in patients with a hepatitis C virus infection. Balkan Journal of Medical Genetics 2016; 19(2): 35 doi: 10.1515/bjmg-2016-0034
|
| 11 |
Hala O. El-Mesallamy, Nadia M. Hamdy, Hanan H. Rizk, Abdel-Rahman El-Zayadi. Apelin Serum Level in Egyptian Patients with Chronic Hepatitis C. Mediators of Inflammation 2011; 2011: 1 doi: 10.1155/2011/703031
|
| 12 |
Chun-che Lin, Mei-chin Yin. Clinical significance of circulating IL-10 and fibronectin levels in hepatocellular carcinoma patients with HBV infection. BioMedicine 2012; 2(3): 122 doi: 10.1016/j.biomed.2012.06.003
|
| 13 |
Rosario González-Casas, María Trapero-Marugán, Ricardo Moreno-Otero. Hepatitis crónica por virus de la hepatitis C genotipo 4. Medicina Clínica 2011; 137(1): 31 doi: 10.1016/j.medcli.2010.03.022
|
| 14 |
Abdel-Rahman N Zekri, Abeer A Bahnassy, Waleed S Mohamed, Hanaa M Alam EL-Din, Hend I Shousha, Naglaa Zayed, Dina H Eldahshan, Ashraf Omar Abdel-Aziz. Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon. Virology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-218
|
| 15 |
Cho Naing, Joon Wah Mak, Nyunt Wai, Mala Maung. Diabetes and Infections-Hepatitis C: Is There Type 2 Diabetes Excess in Hepatitis C Infection?. Current Diabetes Reports 2013; 13(3): 428 doi: 10.1007/s11892-013-0370-3
|
| 16 |
Amr Elrabat, Shahera Eletreby, Ahmed M. Ali Zaid, Mohammed H. Eldeen Zaghloul. Tumor necrosis factor-alpha and alpha-fetoprotein as biomarkers for diagnosis and follow-up of hepatocellular carcinoma before and after interventional therapy. The Egyptian Journal of Internal Medicine 2019; 31(4): 840 doi: 10.4103/ejim.ejim_73_19
|
| 17 |
Barbara Roe, William W. Hall. Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus. Expert Reviews in Molecular Medicine 2008; 10 doi: 10.1017/S1462399408000847
|
| 18 |
Zakaria Y. Mohran, Fatma A. Ali-Eldin, Hala A. Abdel Aal. Serum interleukin-18: Does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma?. Arab Journal of Gastroenterology 2011; 12(1): 29 doi: 10.1016/j.ajg.2010.11.002
|
| 19 |
A. R. N. Zekri, H. A. Haleem, G. E. ‐D. Esmat, A. A. Bahnassy, H. M. A. El‐Din, M. M. Hafez, A. F. Sharaby, H. Sharaf, M. S. E.‐D. Zakaria. Immunomodulators, sFas and Fas‐L as potential noninvasive predictors of IFN treatment in patients with HCV genotype‐4. Journal of Viral Hepatitis 2007; 14(7): 468 doi: 10.1111/j.1365-2893.2006.00832.x
|
| 20 |
Hoda Mohamed El-Emshaty, Wesam Ahmad Nasif, Ibrahim Eldsoky Mohamed. Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/707254
|
| 21 |
Elham Sobhy Said, Noha Mohamed El Husseiny, Nehad A. Mosaad. Evaluation of Serum Level of Tumor Necrosis Factor Receptor II in Hepatitis C Virus (Genotype 4)-Infected Middle-Aged Men with and without Diabetes and Its Complications in Egypt: A Pilot Study. Journal of Investigative Medicine 2011; 59(8): 1276 doi: 10.2310/JIM.0b013e31823908ca
|
| 22 |
Mohamed Elashri, Farag M. Farag, Nader El-Malky, Elsayed Abd Elmaksood, Mohammed Elarman. Serum level of interleukin-8 and interleukin-10 as predictors for response to interferon–ribavirin combined therapy. Egyptian Liver Journal 2016; 6(1): 7 doi: 10.1097/01.ELX.0000481902.94221.61
|
| 23 |
Vikas Verma, Anita Chakravarti, Premashis Kar. Cytokine Levels of TGF-β, IL-10, and sTNFαRII in Type C Chronic Liver Disease. Digestive Diseases and Sciences 2008; 53(8): 2233 doi: 10.1007/s10620-007-0130-9
|
| 24 |
Anuradha Budhu, Xin Wei Wang. The role of cytokines in hepatocellular carcinoma. Journal of Leukocyte Biology 2006; 80(6): 1197 doi: 10.1189/jlb.0506297
|
| 25 |
Moana Gelu-Simeon, Didier Samuel. Role of cytokine levels in assessment of prognosis and post-treatment outcome in hepatocellular carcinoma. Hepatology International 2013; 7(3): 788 doi: 10.1007/s12072-013-9441-4
|
| 26 |
Jinhwa Lee. Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular Carcinoma. The Korean Journal of Physiology & Pharmacology 2013; 17(5): 375 doi: 10.4196/kjpp.2013.17.5.375
|
| 27 |
Manuela G. Neuman, Kristi K. McKinney, Radu M. Nanau, Vincent Kong, Izabella Malkiewicz, Tony Mazulli, George Moussa, Lawrence B. Cohen. Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation. Translational Research 2013; 161(5): 430 doi: 10.1016/j.trsl.2012.12.012
|
| 28 |
Jingkun Liu, Linbang Wang, Wenjun Wang, Yaping Li, Xiaoli Jia, Song Zhai, Juan Shi, Shuangsuo Dang. Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus. Molecular Medicine Reports 2016; 14(3): 2379 doi: 10.3892/mmr.2016.5527
|
| 29 |
Kholoud Baraka, Rania R. Abozahra, Eman Badr, Sarah M. Abdelhamid. Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11420-1
|
| 30 |
Arup Banerjee, Ratna B. Ray, Ranjit Ray. Oncogenic Potential of Hepatitis C Virus Proteins. Viruses 2010; 2(9): 2108 doi: 10.3390/v2092108
|
| 31 |
Shallu Tomer, Yogesh K Chawla, Ajay Duseja, Sunil K Arora. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection. World Journal of Gastroenterology 2016; 22(22): 5173-5182 doi: 10.3748/wjg.v22.i22.5173
|
| 32 |
Soheil Tavakolpour, Shahnaz Sali. Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis. Hepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.33537
|
| 33 |
Khairul Anwar Zarkasi, Noraidatulakma Abdullah, Nor Azian Abdul Murad, Norfazilah Ahmad, Rahman Jamal. Genetic Factors for Coronary Heart Disease and Their Mechanisms: A Meta-Analysis and Comprehensive Review of Common Variants from Genome-Wide Association Studies. Diagnostics 2022; 12(10): 2561 doi: 10.3390/diagnostics12102561
|
| 34 |
Abdel‐Rahman N Zekri, Abeer A Bahnassy, Sabrin A Abdel‐Wahab, Medhat M Khafagy, Samah A Loutfy, Hessam Radwan, Sabry M Shaarawy. Expression of pro‐ and anti‐inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV‐genotype‐4. Journal of Gastroenterology and Hepatology 2009; 24(3): 416 doi: 10.1111/j.1440-1746.2008.05699.x
|
| 35 |
Giuseppe Castello, Stefania Scala, Giuseppe Palmieri, Steven A. Curley, Francesco Izzo. HCV-related hepatocellular carcinoma: From chronic inflammation to cancer. Clinical Immunology 2010; 134(3): 237 doi: 10.1016/j.clim.2009.10.007
|
| 36 |
Mohamed S. Othman, Ahmed M. Aref, Amal A. Mohamed, Wesam A. Ibrahim. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients. ISRN Hepatology 2013; 2013: 1 doi: 10.1155/2013/412317
|
| 37 |
Daniel Fuster, Judith I. Tsui, Debbie M. Cheng, Emily K. Quinn, Kaku A. Armah, David Nunes, Matthew S. Freiberg, Jeffrey H. Samet. Interleukin-6 Is Associated with Noninvasive Markers of Liver Fibrosis in HIV-Infected Patients with Alcohol Problems. AIDS Research and Human Retroviruses 2013; 29(8): 1110 doi: 10.1089/aid.2012.0348
|
| 38 |
Ajax M. Atta, Isabela S. Oliveira, Gabriel M. Sousa, Raymundo Paraná, Maria L. Sousa Atta. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies. Microbial Pathogenesis 2010; 48(2): 53 doi: 10.1016/j.micpath.2009.12.002
|
| 39 |
Iman S. Naga, Amel Abdel Fattah Kamel, Said Ahmed Ooda, Hadeer Muhammad Fath Elbab, Rania Mohamed El-Sharkawy. Effect of directly acting anti-viral agents on immunological imprints in chronic HCV-4a patients: interleukin-10 and vascular endothelial growth factor genes expression level. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00108-5
|
| 40 |
Esmail Mohamad El-Fakharany, Nawal Abd El-Baky, Mustafa Hassan Linjawi, Abdullah Abdelhafiz Aljaddawi, Tahya Hussein Saleem, Ahmed Yassine Nassar, Ashraf Osman, Elrashdy Moustafa Redwan. Influence of camel milk on the hepatitis C virus burden of infected patients. Experimental and Therapeutic Medicine 2017; 13(4): 1313 doi: 10.3892/etm.2017.4159
|
| 41 |
Abdel-Rahman Nabawy Zekri, Amira Salah El-Din Youssef, Yasser Mabrouk Bakr, Reham Mohamed Gabr, Ola Sayed Ahmed, Mostafa Hamed Elberry, Ahmed Mahmoud Mayla, Mohamed Abouelhoda, Abeer A Bahnassy. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model. World Journal of Gastroenterology 2016; 22(16): 4168-4182 doi: 10.3748/wjg.v22.i16.4168
|
| 42 |
Abeer A Mabrouk, Nadia A. Eltablawy, Raouf M.M. El-Allawy, H.A. Abdel Maksoud, Yakout A. Elsenosi. The ameliorating effect of Terminalia muelleri extract on oxidative stress–related factors in induced hepatocellular carcinoma rat model. Gene Reports 2022; 26: 101482 doi: 10.1016/j.genrep.2021.101482
|